Zidovudine, trimethoprim, and dapsone pharmacokinetic interactions in patients with human immunodeficiency virus infection

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 5, 1996, Pages 1231-1236

  Lee, Belle L ^a,b   Safrin, Sharon ^a   Makrides, Vicki ^a   Gambertoglio, John G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DAPSONE; TRIMETHOPRIM; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; DRUG COMPETITION; DRUG GLUCURONIDATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY CLEARANCE; LIVER DISEASE; LYMPHOCYTE SUBPOPULATION; MALE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL;

EID: 0029865321     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.5.1231     Document Type: Article

References (37)

1. Ahmad, R. A., and H. J. Rogers. 1980. Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine. Br J. Clin Pharmacol. 10:519-524.
2. Benet, L. Z., and R. L. Williams. 1990 Design and optimization of dosage regimens. pharmacokinetic data. In A G. Gilman, T. W. Rall. A. S. Nies, and P. Taylor (ed.), Goodman and Gilman's the pharmacological basis of therapeutics, 8th ed. Pergamon Press, Inc , New York.
3. Bowden, F. J., P. J. Harman, and C. R. Lucas. 1986 Serum trimethoprim and sulfamethoxazole levels in AIDS Lancet i:853.
4. Chatton, J. Y., A. Munafo, J. P. Chave. F. Steinhauslin, F. Roch-Ramel, M. P. Glauser, and J. Biollaz. 1992. Trimethoprim, alone or in combination with sulphamethoxazole, decreases the renal excretion of zidovudine and its glucuronide. Br. J. Clin. Pharmacol. 34:551-554.
5. Child, S., J. Montaner, C. Tsoukas, M. Fanning, T. Le, R. A. Wall, and J. Ruedy. 1991 Canadian multicenter azidolhymidine trial: AZT pharmacokinetics J. Acquired Immune Defic. Syndr. 4:865-870
6. Cload, P. A. 1989. A review of the pharmacokinetics of zidovudine in man. J. Infect. 18:15-21.
7. de Miranda, P., S. S. Good, R. Yarchuan, R. V. Thomas, M. R. Blum, C. E. Jyers, and S. Broder. 1989. Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex. Clin. Pharmacol Ther 46:494-500.
8. Gelber, R., J. H. Peters, G. R. Gordon, A. J. Glazko, and L. Levy. 1971 The polymorphic acetylation of dapsone in man. Clin. Pharmacol. Ther 12:225-238.
9. Ghezzi, P., B. Saccardo. and M. Bianchi. 1986 Recombinant tumor necrosis factor depresses cytochrome P450-dependent microsomal drug metabolism in mice. Biochem. Biophys. Res. Commun. 136:316-321.
10. Good, S. S., D. J. Reynolds, and P. de Miranda. 1988. Simultaneous quantification of zidovudine and its glucuronide in serum by high performance liquid chromatography J Chromatogr. 431:123-133.
11. Gordin, F. M., G. L. Simon, C. B. Wofsy, and J. Mills. 1984. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann. Intern Med. 100:495-499
12. Hansen, J. M., J. P. Kampmann, K. Siersbaek-Nielsen, I. B. Lumholtz, M. Arroe, U. Abildgaard, and L. Skovsted. 1979. The effect of different sulfonamides on phenytoin metabolism in man Acta Med. Scand Suppl. 624:106-110.
13. Hegnstmann, J. H. 1982. Pharmacokinetics of trimethoprim and tetroxoprim, Antibiot. Chemother. 31:211-225
14. Hughes, W. T., S. Feldman, S. C. Chaudhary, M. J. Ossi, F. Cox, and S. K. Sanyal. 1978 Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of pneumocystis carinii pneumonia. J. Pediatr 92:285-291
15. Hutabarat, R. M., J. D. Unadkat, C. Sahajwalla, S. McNamara, B. Ramsey, and A. L. Smith. 1991 Disposition of drugs in cystic fibrosis. Sulfamethoxazole and trimethoprim Clin. Pharmacol. Ther. 49:402-409.
16. Kaufman, J. M., and H. E. Fauver. 1980. Potentiation of warfarin by trimethoprim-sulfamethoxazole. Urology 16:601-603.
17. Kornhauser, D. M., B. G. Petty, and C. W. Hendrix. 1989. Probenecid and zidovudine metabolism. Br Med. J. 2:473-475.
18. Kosoglou, T., M. L. Rocci, and P. H. Vlasses. 1988. Trimethoprim alters the disposition of procainamide and N-acetylprocainamide Clin. Pharmacol Ther. 44:467-477.
19. Lähdevirta, J., C. P. J. Maury, A. M. Teppo, and H. Repo. 1988. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med 85:289-291.
20. Lee, B. L., I. Medina, N. L. Benowitz, P. Jacob, C. Wofsy, and J. Mills. 1989. Dapsone, trimethoprim and sulfamethoxazole plasma levels during treatment of pneumocystis pneumonia in patients with acquired immunodeficiency syndrome (AIDS): evidence of drug interactions. Ann. Intern. Med. 110:606-611.
21. Lee, B. L., D. Wong, N. L. Benowitz, and P. M. Sullam. 1993. Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome. Clin. Pharmacol Ther. 53:529-535.
22. May, D. G., J. A. Porter, J. P. Uetrecht, G. R. Wilkinson, and R. A. Branch. 1990. The contribution of N-hydroxylation and acetylation to dapsone pharmacokinetics in normal subjects. Clin. Pharmacol. Ther. 48:619-627.
23. Medina, I., J. Mills, G. S. Leoung, B. L. Lee, N. L. Benowitz, P. C. Hopewell, and C. Wofsy. 1990. Oral therapy for Pneumocystis carinii pneumonia of acquired immunodeficiency syndrome. N. Engl. J. Med. 323:776-782.
24. Patel, R. B., and P. G. Welling. 1980. Clinical pharmacokinetics of cotrimoxazole (trimethoprim-sulfamethoxazole). Clin. Pharmacokinet 5:405-423.
25. Petersen, P., J. Kastrup, R. Bartram, and J. M. Hansen. 1985. Digoxintrimethoprim interaction. Acta Med. Scand. 217:423-427.
26. Reddy, M. M., S. J. Sorrell, M. Lange, and M. H. Grieco. 1988. Tumor necrosis factor and HIV P24 antigen levels in serum of HIV-infected population. J. Acquired Immune Defic. Syndr. 1:436-440.
27. Sahai, J., K. Gallicano, G. Garber, A. Pakuts, N. Hawley-Foss, L. Huang, I. McGilveray, and D. W. Cameron. 1992 Evaluation of the in vivo effect of naproxen on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus. Clin. Pharmacol. Ther. 52:464-470.
28. Sattler, F. R., R. Cowan, D. M. Nilelsen, and J. Ruskin. 1988. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. A prospective, noncrossover study. Ann. Intern. Med. 109:280-287.
29. Singlas, E., J. C. Pioger, A. M. Taburet, S. Colaneri, and J. P. Fillastre. 1989. Comparative pharmacokinetics of zidovudine (AZT) and its metabolite (GAZT) in healthy subjects and HIV seropositive patients. Eur. J. Clin Pharmacol. 36:639-640.
30. Spreux-Varoquaux, O., J. P. Chapalain, P. Cordonnier, C. Advenier, M. Pays, and L. Lamine. 1983. Determination of trimethoprim, sulphamethoxazole and its N4-acetyl metabolite in biological fluids by high performance liquid chromatography. J. Chromatogr. 274:187-199.
31. Stevens, R. C., S. C. Laizure, P. L. Sanders, and D. S. Stein. 1993. Multiple-dose pharmacokinetics. of 12 milligrams of trimethoprim and 60 milligrams of sulfamethoxazole per kilogram of body weight per day in healthy volunteers. Antimicrob. Agents Chemother. 37:448-452.
32. Vergin, H., H. Ferber, I. Zimmermann, and G. B. Neurath. 1981. Single and multiple dose kinetics of co-tetroxazine and co-trimoxazole in patients. Int J. Clin. Pharmacol. Ther. Toxicol. 19:350-357.
33. Weber, W. W., and D. W. Hein. 1985. N-acetylation pharmacogenetics. Pharmacol. Rev. 37:25-79.
34. Wing, L. M., and J. O. Miners. 1985. Cotrimoxazole as an inhibitor of oxidative drug metabolism: effects of trimethoprim and sulphamethoxazole separately and combined on tolbutamide disposition. Br. J. Clin. Pharmacol. 20:482-485.
35. Winston, D. J., W. K. Lau, R. P. Gale, and L. S. Young. 1980. Trimethoprim-sulfamethoxazole for the treatment of pneumocystis carinii pneumonia. Ann. Intern. Med. 92:762-769.
36. Wormser, G. P., G. T. Keusch, and R. C. Heel. 1982. Co-trimoxazole (trimethoprim-sulfamethoxazole). an updated review of its antibacterial activity and clinical efficacy. Drugs 24:459-518.
37. Zuidema, J., E. S. M. Hilbers-Modderman, and F. W. H. M. Merkus. 1986 Clinical pharmacokinetics of dapsone. Clin. Pharmacokinet. 11:299-315.